StreetAlpha
13F holdings · Q3 2026

Vitruvian Partners

London, X0 · files as Vitruvian Partners LLP
Know the moment Vitruvian Partners filesYou follow Vitruvian Partners An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Holdings as of Sep 30, 2026Filed Nov 13, 2026Next filing due Feb 15, 2027CIK 1692590

Vitruvian Partners reported 8 stocks worth $113M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are HNGE (38.6%), MQ (25.7%) and XMTR (13.3%). Compared with Q2 2026, the fund opened new positions in MQ, trimmed HNGE, XMTR and CARG and sold out of MQ.

Latest filing: what Vitruvian Partners did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
1 new0 added3 trimmed1 sold outBought about $29.1M · sold about $124M
New 1
Added 0

None

Trimmed 3
Sold out 1

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$113M−43.6% vs last quarter
Stocks held81 new · 1 sold out
Top 5 weight91.0%very concentrated
Turnover136%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
HNGE
Hinge Health Inc
$43.8M38.6%450K−57K (−11%)6 of 8
2
MQ
Marqeta Inc-A
$29.1M25.7%1.7MNew position1 of 8
3
XMTR
Xometry Inc
$15M13.3%146K−35K (−19%)8 of 8
4
GLBE
Global E Online Ltd
$8.4M7.4%210KNo change7 of 8
5
CARG
Cargurus Inc
$6.9M6.0%220K−130K (−37%)8 of 8
6
MXCT
Maxcyte Inc
$5.6M5.0%5MNo change8 of 8
7
WSE
Wise Group PLC Ord Shs Class A
$3.2M2.8%281KNo change2 of 8
8
RXST
Rxsight Inc
$1.4M1.2%279KNo change8 of 8

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
MQ
Marqeta Inc
$111M6.9M

Reported value

last 8 quarters
$116MQ4 '24
$105MQ1 '25
$164MQ2 '25
$144MQ3 '25
$139MQ4 '25
$112MQ1 '26
$201MQ2 '26
$113MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 13, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Vitruvian Partners 13F FAQ

What does Vitruvian Partners own?

Vitruvian Partners reported 8 stocks worth $113M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are HNGE (38.6%), MQ (25.7%) and XMTR (13.3%). The table above lists every position in the filing (the top 10 without an account).

What did Vitruvian Partners buy and sell in Q3 2026?

Compared with Q2 2026: 1 new positions, 0 added to, 3 trimmed and 1 sold out. New positions include MQ. It sold all of MQ.

When will Vitruvian Partners file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Vitruvian Partners's portfolio worth?

The Q3 2026 filing reports $113M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.